ID

34555

Description

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01251120

Lien

https://clinicaltrials.gov/show/NCT01251120

Mots-clés

Versions (1)
  1. 19/01/2019 19/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

19 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Rheumatoid Arthritis NCT01251120

Anglais

Eligibility Rheumatoid Arthritis NCT01251120

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, over the age of 18 years
Description

ID.1

Type de données

boolean

diagnosis of moderate-to-severe active early rheumatoid arthritis (ra) of less than 2 years duration
Description

ID.2

Type de données

boolean

das28 >3.2
Description

ID.3

Type de données

boolean

swollen joint count (sjc) >/=6 (66 joint count), and tender joint count (tjc) >/=6 (68 joint count)
Description

ID.4

Type de données

boolean

patients who have received dmards (including methotrexate) for 3-7 months
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months after baseline
Description

ID.6

Type de données

boolean

rheumatic autoimmune disease other than rheumatoid arthritis (secondary sjögrens syndrome or nodulosis with ra is permitted)
Description

ID.7

Type de données

boolean

functional class iii or iv as defined by acr classification of functional status in rheumatoid arthritis
Description

ID.8

Type de données

boolean

prior history of or current inflammatory joint disease other than ra
Description

ID.9

Type de données

boolean

Retour au début de la page

Similar models

Eligibility Rheumatoid Arthritis NCT01251120

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
adult patients, over the age of 18 years
boolean
ID.2
Item
diagnosis of moderate-to-severe active early rheumatoid arthritis (ra) of less than 2 years duration
boolean
ID.3
Item
das28 >3.2
boolean
ID.4
Item
swollen joint count (sjc) >/=6 (66 joint count), and tender joint count (tjc) >/=6 (68 joint count)
boolean
ID.5
Item
patients who have received dmards (including methotrexate) for 3-7 months
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months after baseline
boolean
ID.7
Item
rheumatic autoimmune disease other than rheumatoid arthritis (secondary sjögrens syndrome or nodulosis with ra is permitted)
boolean
ID.8
Item
functional class iii or iv as defined by acr classification of functional status in rheumatoid arthritis
boolean
ID.9
Item
prior history of or current inflammatory joint disease other than ra
boolean
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial